Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-23 4:36 pm Sale |
2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Iroquois Capital Management, LLC | 6,667 0.240% |
-54,667 (-89.13%) |
Filing History |
| 2022-02-09 11:08 am Sale |
2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Parian Global Management LP | 0 0.000% |
-79,983 (Position Closed) |
Filing History |
| 2022-02-04 3:19 pm Sale |
2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Hudson Bay Capital Management LP | 0 0.000% |
-61,333 (Position Closed) |
Filing History |
| 2021-03-01 4:38 pm Purchase |
2021-02-22 | 13G | Artelo Biosciences, Inc. ARTL |
Parian Global Management LP | 79,983 7.640% |
79,983 (New Position) |
Filing History |
| 2021-02-16 09:53 am Sale |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
CVI Investments, Inc. | 52,911 4.900% |
-8,422 (-13.73%) |
Filing History |
| 2021-02-10 4:12 pm Unchanged |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
BIGGER CAPITAL FUND L P | 60,000 4.990% |
0 (Unchanged) |
Filing History |
| 2021-02-08 5:07 pm Purchase |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Hudson Bay Capital Management LP | 61,333 5.740% |
61,333 (New Position) |
Filing History |
| 2021-02-05 4:23 pm Unchanged |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
KINGSBROOK PARTNERS LP | 53,333 4.990% |
0 (Unchanged) |
Filing History |
| 2021-01-15 11:30 am Sale |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 52,267 4.990% |
-1,066 (-2.00%) |
Filing History |
| 2021-01-13 09:02 am Unchanged |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Empery Asset Management, LP | 61,333 4.990% |
0 (Unchanged) |
Filing History |
| 2020-10-26 06:09 am Unchanged |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-10-22 1:18 pm Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 53,333 5.290% |
53,333 (New Position) |
Filing History |
| 2020-10-19 4:33 pm Purchase |
2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL |
BIGGER CAPITAL FUND L P | 60,000 5.800% |
60,000 (New Position) |
Filing History |
| 2020-10-19 3:25 pm Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
Iroquois Capital Management, LLC | 61,333 6.670% |
61,333 (New Position) |
Filing History |
| 2020-10-15 10:54 am Purchase |
2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL |
Empery Asset Management, LP | 61,333 6.670% |
61,333 (New Position) |
Filing History |
| 2020-10-15 10:17 am Purchase |
2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL |
CVI Investments, Inc. | 61,333 6.700% |
61,333 (New Position) |
Filing History |
| 2020-10-15 08:45 am Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
KINGSBROOK PARTNERS LP | 53,333 5.800% |
53,333 (New Position) |
Filing History |